Dr Samir Agrawal

Samir Agrawal is a Senior Lecturer in Haematology at the Queens Mary University of London and a Consultant Haemato-Oncologist at St Bartholomew’s Hospitals and The Barts Health NHS Trust, London UK. His expertise is in the treatment of blood cancers and in stem cell transplantation. He has a specialist interest in chronic lymphocytic leukaemia, lymphomas and rare lymphoproliferative disorders. He is a recognised expert in the field of infections in immunocompromised patients with cancer and a world authority on life-threatening invasive fungal infections. He maintains academic activities, publishing in the leading medical journals and lecturing internationally. He qualified at the University of Bristol, trained in London and at the Royal Marsden Cancer Hospital, was awarded his PhD “1st class with honours” (in Tumour Immunology) at the University of Paris. He is a fluent French speaker and was a national junior chess champion. He is a former Director of The Stem Cell Laboratory and Head of Diagnostic Immunophenotyping. He has designed, funded, and implemented studies on myelodysplastic syndromes, invasive aspergillosis, and chronic lymphocytic leukaemia. He was a founding Trustee of the UK MDS group, a former trustee for CLL Support (the patient-led UK charity helping patients with CLL), and remains their medical advisor, as well as a NICE reviewer. His current activities are in the field of invasive fungal disease, chronic lymphocytic leukaemia, systems for “remote care” for patients. He is a member of the fungal subgroup of government committee on antimicrobial resistance, ESPAUR.

Dr Agrawal has particular expertise in CLL, managing infection in patients dealing with cancer and cancer therapies, and providing holistic support looking beyond the conventional medical model. He has expertise in the use of repurposed medicines for cancer.